scispace - formally typeset
O

Olivier Stevens

Researcher at Katholieke Universiteit Leuven

Publications -  8
Citations -  636

Olivier Stevens is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Complement inhibitor & Gene. The author has an hindex of 3, co-authored 7 publications receiving 414 citations.

Papers
More filters
Journal ArticleDOI

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, +623 more
- 01 Dec 2017 - 
TL;DR: A phase 3, randomised, double-blind, placebo-controlled, multicentre study in 76 hospitals and specialised clinics across North America, Latin America, Europe, and Asia to assess the efficacy and safety of eculizumab in patients with refractory myasthenia gravis.
Journal ArticleDOI

Diagnostic Challenges and Clinical Characteristics of Hepatitis E Virus-Associated Guillain-Barré Syndrome.

TL;DR: Acute HEV infection was frequently associated with GBS in a Belgian cohort and further studies are required to guide neurologists in their workup of underlying triggers of GBS.
Journal ArticleDOI

Consistent improvement with eculizumab across muscle groups in myasthenia gravis

Renato Mantegazza, +554 more
TL;DR: Whether eculizumab, a terminal complement inhibitor, improves patient‐ and physician‐reported outcomes in patients with refractory anti‐acetylcholine receptor antibody‐positive generalized myasthenia gravis across four domains is investigated.